A Huntington’s gene therapy by UniQure has made waves after slowing disease progression by 75% in a mid-stage trial. During the Phase I/II study (NCT05243017), patients treated with a high dose of AMT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results